The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
TH1/17 hybrid CD4+ cells in bronchial alveolar lavage fluid from leukemia patients with checkpoint inhibitor-induced pneumonitis.
 
Sang Kim
No Relationships to Disclose
 
Vickie Shannon
No Relationships to Disclose
 
Ajay Sheshadri
No Relationships to Disclose
 
Hagop M. Kantarjian
Honoraria - Abbvie; Amgen; ARIAD; Bristol-Myers Squibb; Immunogen; Orsenix; Pfizer
Research Funding - Amgen (Inst); ARIAD (Inst); Astex Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst); Pfizer (Inst)
 
Guillermo Garcia-Manero
No Relationships to Disclose
 
Jin Im
No Relationships to Disclose
 
Farhad Ravandi
No Relationships to Disclose
 
Aung Naing
Consulting or Advisory Role - CytomX Therapeutics; Novartis
Research Funding - Amplimmune; ARMO BioSciences; Atterocor; EMD Serono; Healios; Incyte; Karyopharm Therapeutics; MedImmune; NCI; Novartis; Regeneron
Travel, Accommodations, Expenses - ARMO BioSciences
 
Andrew Futreal
Research Funding - MEI Pharma
 
Naval Guastad Daver
Honoraria - BMS Brazil; Daiichi Sankyo; ImmunoGen; Incyte; Karyopharm Therapeutics; Kiromic; Otsuka; Pfizer
Research Funding - BMS Brazil; Daiichi Sankyo; ImmunoGen; Incyte; Karyopharm Therapeutics; Kiromic; Otsuka; Pfizer